Advanced in Dilated Cardiomyopathy (DCM)

Wei N. Dong

28 Fuxing Street, 
Beijing, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Dilated Cardiomyopathy (DCM)
28 Fuxing Street, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Wei Dong practices in Beijing, China. Dong is rated as an Advanced expert by MediFind in the treatment of Dilated Cardiomyopathy (DCM). Their top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Unstable Angina, Acute Coronary Syndrome, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 188 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Dilated Cardiomyopathy (DCM).

Locations

28 Fuxing Street, Beijing, 100853, China
Other Locations
No. 119, South Fourth Ring West Road, Fengtai, 100070, China
Tat Chee Avenue, Hong Kong, China
106, Zhong Shan Road 2, Guangzhou, 510080, China
No. 38 Xueyuan Road, Beijing, 100191, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.
A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.
Enrollment Status: Recruiting
Publish Date: February 01, 2024
Intervention Type: Drug
Study Drug: rhNRG-1
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure on Standard Heart Failure Therapy
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure on Standard Heart Failure Therapy
Enrollment Status: Completed
Publish Date: July 25, 2024
Intervention Type: Drug
Study Drug: Recombinant Human Neuregulin for Injection
Study Phase: Phase 3
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
Enrollment Status: Terminated
Publish Date: December 21, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

188 Total Publications

Correction to "Salecan-Based pH-Sensitive Hydrogels for Insulin Delivery".
Correction to "Salecan-Based pH-Sensitive Hydrogels for Insulin Delivery".
Journal: Molecular pharmaceutics
Published: July 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dong's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 28 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile